How Much Does Crestor (Rosuvastatin) Cost in Virginia in 2026?

Brand vs. Generic Pricing in Virginia

The single biggest factor in what you pay for rosuvastatin in Virginia is whether you fill brand-name Crestor or a generic equivalent. Brand Crestor carries a manufacturer list price of approximately $290 per month from AstraZeneca. Generic rosuvastatin, available since 2016 when Crestor's patent exclusivity expired, averages around $15 per month at Virginia retail pharmacies in 2026.

That price gap is not unusual for statins. The FDA approved rosuvastatin in 2003 for hyperlipidemia and cardiovascular risk reduction, and once generic competition entered the market, cash prices dropped by more than 90%. Virginia has over 2,000 licensed retail pharmacies, and pricing can still vary by $5 to $12 between locations for the same generic product. Chains like CVS, Walgreens, and Kroger pharmacies across Northern Virginia, Hampton Roads, and the Richmond metro area each set their own generic pricing tiers.

If your prescriber writes "Crestor" with "dispense as written" (DAW), your pharmacy must fill the brand. Without that designation, Virginia substitution law (Virginia Code § 54.1-3401 et seq.) allows pharmacists to automatically substitute an FDA-rated generic equivalent. Ask your provider to leave the DAW box unchecked if cost matters to you. That one checkbox is often the difference between a $290 bill and a $15 one [1].

Virginia Medicaid Coverage for Rosuvastatin

Virginia Medicaid covers rosuvastatin, but a prior authorization (PA) requirement applies. This means your prescriber must submit clinical documentation showing that rosuvastatin is medically necessary before Medicaid will pay for the prescription.

In practice, the PA process for statins in Virginia Medicaid is straightforward when a patient has a documented diagnosis of hyperlipidemia or meets criteria for primary prevention of atherosclerotic cardiovascular disease (ASCVD). The 2018 AHA/ACC Cholesterol Guideline identifies four statin-benefit groups, and Virginia Medicaid generally follows these categories when evaluating PA requests [2]. Patients with clinical ASCVD, LDL-C ≥ 190 mg/dL, diabetes aged 40 to 75, or a 10-year ASCVD risk ≥ 7.5% typically receive approval.

Virginia expanded Medicaid under the Affordable Care Act in 2019, bringing coverage to adults earning up to 138% of the federal poverty level. That expansion added over 600,000 Virginians to Medicaid rolls, many of whom had previously gone without statin therapy despite meeting guideline criteria. If your PA is denied, Virginia Medicaid allows a prescriber-initiated appeal. The turnaround for urgent appeals is 24 hours; standard appeals take up to 30 days.

Generic rosuvastatin is placed on Virginia Medicaid's preferred drug list (PDL) at a lower tier than brand Crestor, which means copays are lower for the generic. Most Virginia Medicaid managed care organizations (MCOs), including Aetna Better Health of Virginia, Anthem HealthKeepers, Molina, and United Healthcare Community Plan, follow the state PDL for statin coverage [3].

Insurance and Commercial Plan Coverage

Most commercial insurance plans sold on Virginia's Health Insurance Marketplace and employer-sponsored plans cover generic rosuvastatin at Tier 1 or Tier 2 copay levels. That typically means $0 to $15 per month after any deductible, though plan designs vary.

Brand Crestor, when covered, usually sits at Tier 3 (preferred brand) or Tier 4 (non-preferred brand). Copays at those tiers run $35 to $75 per month in most Virginia commercial plans, and some high-deductible health plans (HDHPs) require the full cash price until the deductible is met. The Affordable Care Act mandates coverage of statin therapy for adults aged 40 to 75 with cardiovascular risk factors as a preventive service with no cost-sharing under USPSTF Grade B recommendations [4]. This means if your prescriber documents that your statin is for primary ASCVD prevention and your plan follows ACA preventive-service rules, you may owe $0 for generic rosuvastatin.

Virginia state employees covered under the COVA Health plan and COVA HDHP plan have generic rosuvastatin on the formulary. Federal employees in Virginia using FEHB plans also have broad generic statin coverage. TRICARE beneficiaries at Virginia's military installations (Fort Barfoot, Joint Base Langley-Eustis, Naval Station Norfolk, Quantico) can fill generic rosuvastatin at military pharmacies for $0 or at retail network pharmacies for a $14 copay under the TRICARE pharmacy benefit [5].

Compounded Rosuvastatin in Virginia: Legality and Access

Compounded rosuvastatin is legal in Virginia when dispensed by a licensed 503A compounding pharmacy that holds a valid Virginia Board of Pharmacy permit. Section 503A of the Federal Food, Drug, and Cosmetic Act allows patient-specific compounding by state-licensed pharmacies operating under a valid prescription.

Why would someone choose compounded rosuvastatin over a commercially available generic? The most common reasons are allergy to an inactive ingredient in the manufactured tablet (such as lactose monohydrate or crospovidone), need for a non-standard dose, or need for an alternative dosage form like a liquid suspension for patients with swallowing difficulties. Virginia's Board of Pharmacy regulates 503A pharmacies under 18 VAC 110-20, requiring them to compound in accordance with USP Chapter 795 standards for non-sterile preparations.

503B outsourcing facilities, which operate under federal FDA oversight and can produce larger batches without patient-specific prescriptions, also supply Virginia providers. The distinction matters: 503A pharmacies compound per individual prescription, while 503B facilities can ship compounded products to healthcare facilities for office use. Both are legal pathways in Virginia, but pricing, turnaround time, and availability differ. Some telehealth platforms partner with 503B outsourcing facilities to offer compounded rosuvastatin as part of bundled cardiovascular wellness programs.

The compounded route is not the right fit for most patients. Commercially manufactured generic rosuvastatin is FDA-approved, bioequivalence-tested, and inexpensive. Reserve compounding for situations where the commercially available product genuinely does not work for the patient [6].

Discount Programs and Savings Cards

Several discount pathways can reduce out-of-pocket costs for rosuvastatin in Virginia, even below the $15 average generic price.

Pharmacy discount cards and aggregators. GoodRx, RxSaver, and SingleCare negotiate rates with Virginia pharmacies. These programs are not insurance and cannot be combined with insurance copays, but for uninsured patients or those with high-deductible plans, they can bring generic rosuvastatin to $4 to $10 per month at participating pharmacies. Prices fluctuate weekly, so compare across platforms before filling.

AstraZeneca savings programs. AstraZeneca offers a branded Crestor savings card for commercially insured patients, which can reduce copays to as low as $3 per month for eligible patients. The card does not apply to government-funded insurance (Medicaid, Medicare Part D, TRICARE, VA benefits). Eligibility requirements and annual caps change periodically. Check the program terms each calendar year.

$4 generic lists. Several Virginia chains, including Walmart and Kroger, include rosuvastatin on their $4 per month generic drug lists for common doses (5 mg, 10 mg, 20 mg). The 40 mg dose may not always be included. These programs require no enrollment and no insurance. Simply present a valid prescription and request the store's generic pricing.

340B pricing. Federally Qualified Health Centers (FQHCs) and qualifying hospitals in Virginia that participate in the 340B Drug Pricing Program can dispense rosuvastatin at reduced cost. Virginia has over 30 FQHCs with pharmacy services, concentrated in underserved areas of Southwest Virginia, the Shenandoah Valley, and rural Southside. Patients receiving care at these facilities may access significantly discounted medications regardless of insurance status [7].

Medicare Part D. Virginia Medicare beneficiaries on Part D plans typically pay $1 to $11 per month for generic rosuvastatin, depending on the plan's tier structure and whether the beneficiary has reached the coverage gap. The Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D spending, fully in effect in 2025 and continuing into 2026, provides additional protection for patients taking multiple medications.

Telehealth Prescribing of Rosuvastatin in Virginia

Virginia permits telehealth prescribing of rosuvastatin. The Virginia Board of Medicine allows prescribers to establish a provider-patient relationship via synchronous audio-video telemedicine, and Virginia's telehealth parity law (Virginia Code § 38.2-3418.16) requires commercial insurers to cover telehealth services at the same rate as in-person visits.

This means a Virginia-licensed prescriber can evaluate your lipid panel results, assess your ASCVD risk, and prescribe rosuvastatin during a video visit without requiring an in-person office appointment. For patients in rural parts of Virginia, where cardiologist and endocrinologist access is limited, telehealth removes a significant barrier to guideline-directed statin therapy.

The JUPITER trial (N=17,802) demonstrated that rosuvastatin 20 mg daily reduced the primary cardiovascular endpoint by 44% (HR 0.56, 95% CI 0.46 to 0.69, P<0.00001) in apparently healthy individuals with elevated high-sensitivity C-reactive protein (hsCRP ≥ 2 mg/L) and LDL-C <130 mg/dL [8]. That landmark evidence underpins the broad use of rosuvastatin for primary prevention, and telehealth makes it easier to act on lab results quickly rather than waiting weeks for a follow-up office visit.

Several telehealth platforms operating in Virginia offer statin management as part of cardiovascular or metabolic health programs. These visits typically cost $30 to $75 without insurance. Some platforms bundle the consultation fee with the medication cost, dispensing through partner mail-order or 503B pharmacies.

How Rosuvastatin Compares to Other Statins on Cost

Rosuvastatin is one of two high-intensity statins (the other being atorvastatin 40 to 80 mg). The 2018 AHA/ACC guideline recommends high-intensity statin therapy for patients with clinical ASCVD and for primary prevention in high-risk groups [2]. Both generic rosuvastatin and generic atorvastatin are inexpensive, but small price differences exist.

In Virginia, generic atorvastatin 40 mg averages $8 to $12 per month, while generic rosuvastatin 20 mg averages $12 to $18 per month. The difference is modest. From a clinical standpoint, rosuvastatin 20 mg and atorvastatin 80 mg produce comparable LDL-C reductions of approximately 50% to 55%, though head-to-head data from the STELLAR trial showed rosuvastatin achieved greater LDL-C lowering milligram-for-milligram across all dose comparisons [9].

Choice between the two often comes down to tolerability, drug interactions, and formulary placement rather than efficacy. Rosuvastatin has fewer CYP3A4-mediated drug interactions than atorvastatin, which can matter for patients on concurrent medications like certain calcium channel blockers, macrolide antibiotics, or antifungals [1]. If your insurance plan's formulary favors one generic over the other, that is usually the most practical consideration for a Virginia patient.

Filling Your Prescription: Practical Steps for Virginia Residents

Start with your prescriber. Confirm the prescription is written for generic rosuvastatin (not "Crestor DAW"). Ask your pharmacy to run the claim through your insurance first. If the copay is higher than expected, ask the pharmacist to compare the insurance price against their cash price and any available discount card price. Virginia pharmacists are permitted to inform you of lower-cost alternatives under Virginia's pharmacist gag clause prohibition.

If you are uninsured, compare prices at three or more pharmacies using a discount aggregator. Walmart, Costco (no membership required for pharmacy in Virginia), and independent pharmacies often have the lowest generic prices. For patients on Virginia Medicaid who encounter a PA delay, ask your prescriber's office to submit the PA electronically through the CoverMyMeds or Surescripts network. Electronic PAs are processed faster than fax-based submissions.

For mail-order, 90-day supplies often cost less per tablet than 30-day fills. Many Virginia insurance plans and PBMs offer preferred mail-order pharmacies where a 90-day supply of generic rosuvastatin costs $10 to $25 total. Express Scripts, CVS Caremark, and OptumRx all include rosuvastatin on their mail-order generic lists [10].

Monitor your lipid panel 4 to 12 weeks after starting or changing your rosuvastatin dose, per ACC/AHA monitoring recommendations. A fasting lipid panel at a Virginia Quest Diagnostics or LabCorp location costs $30 to $50 without insurance, and many telehealth platforms include lab orders in their visit fee. Your target: at minimum a 50% reduction in LDL-C from baseline on high-intensity therapy, or LDL-C <70 mg/dL for patients with established ASCVD [2].